The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

ImmuneOnco Biopharmaceuticals has shown Chinese biotechs are far from immune to the pressures to prioritize pipelines. | ...

NEW YORK (Reuters) -Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...

Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with mercurial White House ...

Signaturefd LLC lifted its holdings in Repligen Co. (NASDAQ:RGEN – Free Report) by 172.2% in the 4th quarter, according to ...

Thrivent Financial for Lutherans lessened its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report ...

FDA reviews TNX-102 SL for Fibromyalgia by August 2025, with no advisory required. See why we recommend a buy on TNXP stock.

In the wake of a disappointing market selloff, opportunities for long-term investors are emerging. History indicates that high-quality ASX 200 stocks tend to rebound, offering potential for ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

Humacyte intends to use the net proceeds that it will receive from the offering to fund the commercialization of SYMVESS™ in the vascular trauma indication, the development of the product candidates ...

Investors and market watchers keenly observe ARK’s daily trades, as Cathie Wood’s ETFs are known for their active management and focus on disruptive innovation. The trades provide insights into the ...